51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

24 trials found

diseases per page:

Showing 1 to 10 of 24 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-173760	10/11/2017	07/11/2017	Tocilizumab LTE study in patients with SSc	A PHASE III, MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY O ...	Systemic sclerosis	Intervention name : tocilizumab INN of the intervention : tocilizumab Dosage And administration of the ...	CHUGAI PHARMACEUTICAL CO., LTD	NULL	complete	18		BOTH	18	Phase 3	Japan
2	EUCTR2015-000424-28-IE (EUCTR)	17/10/2016	19/08/2016	A study to assess the efficacy and safety of tocilizumabversus placebo in patients with Systemic Scl ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 19.0;Level: PT;Classification code 10042953;Term: Systemic sclero ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Greece;Spain;Ireland;Switzerland;Italy;France;Denmark;South Africa;Netherland ...
3	JPRN-UMIN000022624	2016/07/01	06/06/2016	Clinical trial of long term efficacy for tocilizumabin systemic sclerosis and sclerodermatous chroni ...	Clinical trial of long term efficacy for tocilizumabin systemic sclerosis and sclerodermatous chroni ...	The patients with systemic sclerosis or sclerodermatous chronic GVHD.	treatment with tocilizumab duration: 116 weeks dosage: 8mg/kg times: 6 times Frequency: every 4 week ...	Kanazawa University Hospital	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	5	Not selected	Japan
4	EUCTR2015-000424-28-GR (EUCTR)	26/01/2016	30/12/2015	A study to assess the efficacy and safety of tocilizumabversus placebo in patients with Systemic Scl ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 18.1;Level: PT;Classification code 10042953;Term: Systemic sclero ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Greece;Spain;Ireland;Switzerland;Italy;France;Denmark;South Africa;Netherland ...
5	JPRN-JapicCTI-152963	08/1/2016	09/07/2015	Phase III Study of Tocilizumab in Patients with Systemic Sclerosis	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis	Intervention name : Tocilizumab INN of the intervention : tocilizumab Dosage And administration of the ...	Chugai Pharmaceutical Co., Ltd.	F.Hoffmann-La Roche Ltd	complete	18		BOTH	210	Phase 3	Japan, North America, Europe, 25 countries including Japan, US, UK, Germany etc.
6	EUCTR2015-000424-28-NL (EUCTR)	22/12/2015	21/09/2015	A study to assess the efficacy and safety of tocilizumabversus placebo in patients with Systemic Scl ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 19.0;Level: PT;Classification code 10042953;Term: Systemic sclero ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Greece;Spain;Ireland;Switzerland;Italy;France;Denmark;South Africa;Netherland ...
7	EUCTR2015-000424-28-HR (EUCTR)	18/12/2015	01/02/2016	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 18.1;Level: PT;Classification code 10042953;Term: Systemic sclero ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 3	Portugal;United States;Greece;Spain;Ireland;Italy;Switzerland;France;Denmark;South Africa;Netherland ...
8	NCT02453256 (ClinicalTrials.gov)	November 20, 2015	21/5/2015	A Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis (SSc)	A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Asse ...	Systemic Sclerosis	Drug: Placebo;Drug: Tocilizumab	Hoffmann-La Roche	NULL	Completed	18 Years	N/A	All	212	Phase 3	United States;Argentina;Belgium;Bulgaria;Canada;Denmark;France;Germany;Greece;Hungary;Italy;Japan;Li ...
9	EUCTR2015-000424-28-DE (EUCTR)	02/11/2015	27/07/2015	A study to assess the efficacy and safety of tocilizumabversus placebo in patients with Systemic Scl ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 20.0;Level: LLT;Classification code 10042953;Term: Systemic scler ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Phase 3	United States;Portugal;Greece;Spain;Ireland;Italy;Switzerland;France;Denmark;South Africa;Netherland ...
10	EUCTR2015-000424-28-LT (EUCTR)	14/10/2015	29/07/2015	A study to assess the efficacy and safety of tocilizumabversus placebo in patients with Systemic Scl ...	A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSE ...	Systemic Sclerosis MedDRA version: 19.0;Level: PT;Classification code 10042953;Term: Systemic sclero ...	Trade Name: RoActemra 162 mg Product Code: RO487-7533/F10-04 INN or Proposed INN: Tocilizumab Other desc ...	F. Hoffmann-La Roche Ltd	NULL	Not Recruiting			Female: yes Male: yes	210	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Portugal;Greece;Spain;Ireland;Switzerland;Italy;France;Denmark;South Africa;Netherland ...

First Previous1 2 3Next Last